Benign Prostatic Hypertrophy (BPH), also known as benign prostatic hyperplasia, is a common non-cancerous condition characterized by the enlargement of the prostate gland. The prostate is a walnut-shaped gland found only in males, located beneath the bladder and surrounding the urethra. As men age, typically after the age of 40, hormonal changes can cause the prostate to grow in size.
In the case of BPH, the increased size of the prostate gland can lead to the narrowing of the urethra, which can then result in various urinary symptoms. These symptoms may include frequent urination, hesitancy or difficulty starting and stopping urine flow, weak urine stream, incomplete emptying of the bladder, and the need to wake up multiple times during the night to urinate.
Although BPH is a benign condition and not directly related to prostate cancer, it can significantly impact the quality of life for affected individuals due to the bothersome urinary symptoms. It is important to note that the presence of BPH does not increase the risk of developing prostate cancer.
Medical evaluation and diagnosis through physical examination, medical history assessment, and possibly further tests such as prostate-specific antigen (PSA) blood test, urine flow study, or ultrasound imaging may be necessary to confirm the BPH diagnosis.
Treatment options for benign prostatic hypertrophy depend on the severity of symptoms, the impact on the individual's quality of life, and the overall health status. Strategies may include lifestyle modifications, medication therapy, minimally invasive procedures, or surgical intervention to relieve the urinary symptoms and improve urinary flow. Regular follow-up and monitoring are essential to ensure the condition does not worsen or cause complications.
